Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

An approach for accelerated isolation of genetically manipulated cell clones with reduced clonal variability.

Casden N, Behar O.

J Cell Sci. 2019 Mar 26;132(6). pii: jcs217661. doi: 10.1242/jcs.217661.

2.

miR126-5p Downregulation Facilitates Axon Degeneration and NMJ Disruption via a Non-Cell-Autonomous Mechanism in ALS.

Maimon R, Ionescu A, Bonnie A, Sweetat S, Wald-Altman S, Inbar S, Gradus T, Trotti D, Weil M, Behar O, Perlson E.

J Neurosci. 2018 Jun 13;38(24):5478-5494. doi: 10.1523/JNEUROSCI.3037-17.2018. Epub 2018 May 17.

3.

ALS-related human cortical and motor neurons survival is differentially affected by Sema3A.

Birger A, Ottolenghi M, Perez L, Reubinoff B, Behar O.

Cell Death Dis. 2018 Feb 15;9(3):256. doi: 10.1038/s41419-018-0294-6.

4.

Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism.

Peretz L, Besser E, Hajbi R, Casden N, Ziv D, Kronenberg N, Gigi LB, Sweetat S, Khawaled S, Aqeilan R, Behar O.

Sci Rep. 2018 Jan 8;8(1):93. doi: 10.1038/s41598-017-18551-z.

5.

Abnormalities in A-to-I RNA editing patterns in CNS injuries correlate with dynamic changes in cell type composition.

Gal-Mark N, Shallev L, Sweetat S, Barak M, Billy Li J, Levanon EY, Eisenberg E, Behar O.

Sci Rep. 2017 Mar 7;7:43421. doi: 10.1038/srep43421.

6.

Overcoming the oral aspects of -self-mutilation: description of a method.

Shapira J, Birenboim R, Shoshani M, Abdel-Kader A, Behar O, Moskovitz M, Ben-Attar Y, Chaushu S, Becker A.

Spec Care Dentist. 2016 Sep;36(5):282-7. doi: 10.1111/scd.12181. Epub 2016 Apr 22.

PMID:
27105292
7.

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies.

Chadwick EJ, Yang DP, Filbin MG, Mazzola E, Sun Y, Behar O, Pazyra-Murphy MF, Goumnerova L, Ligon KL, Stiles CD, Segal RA.

J Vis Exp. 2015 Nov 7;(105):e53304. doi: 10.3791/53304.

8.

Astrogliosis Induced by Brain Injury Is Regulated by Sema4B Phosphorylation

Ben-Gigi L, Sweetat S, Besser E, Fellig Y, Wiederhold T, Polakiewicz RD, Behar O.

eNeuro. 2015 May 25;2(3). pii: ENEURO.0078-14.2015. doi: 10.1523/ENEURO.0078-14.2015. eCollection 2015 May-Jun.

9.

A new impedance based approach to test the activity of recombinant protein--Semaphorins as a test case.

Birger A, Besser E, Reubinoff B, Behar O.

Eur J Cell Biol. 2015 Oct;94(10):453-7. doi: 10.1016/j.ejcb.2015.06.006. Epub 2015 Jun 14.

PMID:
26111659
10.

Elimination of aberrant DRG circuitries in Sema3A mutant mice leads to extensive neuronal deficits.

Ben-Zvi A, Sweetat S, Behar O.

PLoS One. 2013 Jul 26;8(7):e70085. doi: 10.1371/journal.pone.0070085. Print 2013.

11.

The Semaphorin receptor PlexinA3 mediates neuronal apoptosis during dorsal root ganglia development.

Ben-Zvi A, Manor O, Schachner M, Yaron A, Tessier-Lavigne M, Behar O.

J Neurosci. 2008 Nov 19;28(47):12427-32. doi: 10.1523/JNEUROSCI.3573-08.2008.

12.

Semaphorin3A regulates axon growth independently of growth cone repulsion via modulation of TrkA signaling.

Ben-Zvi A, Ben-Gigi L, Yagil Z, Lerman O, Behar O.

Cell Signal. 2008 Mar;20(3):467-79. Epub 2007 Nov 5.

PMID:
18096366
13.

Modulation of semaphorin3A activity by p75 neurotrophin receptor influences peripheral axon patterning.

Ben-Zvi A, Ben-Gigi L, Klein H, Behar O.

J Neurosci. 2007 Nov 21;27(47):13000-11.

14.

Semaphorin3A accelerates neuronal polarity in vitro and in its absence the orientation of DRG neuronal polarity in vivo is distorted.

Lerman O, Ben-Zvi A, Yagil Z, Behar O.

Mol Cell Neurosci. 2007 Oct;36(2):222-34. Epub 2007 Jul 24.

PMID:
17728139
15.

Semaphorin 3A and neurotrophins: a balance between apoptosis and survival signaling in embryonic DRG neurons.

Ben-Zvi A, Yagil Z, Hagalili Y, Klein H, Lerman O, Behar O.

J Neurochem. 2006 Jan;96(2):585-97. Epub 2005 Dec 8.

16.

Coordination of trigeminal axon navigation and patterning with tooth organ formation: epithelial-mesenchymal interactions, and epithelial Wnt4 and Tgfbeta1 regulate semaphorin 3a expression in the dental mesenchyme.

Kettunen P, L√łes S, Furmanek T, Fjeld K, Kvinnsland IH, Behar O, Yagi T, Fujisawa H, Vainio S, Taniguchi M, Luukko K.

Development. 2005 Jan;132(2):323-34. Epub 2004 Dec 16.

18.

Putting the spinal cord together again.

Behar O, Mizuno K, Neumann S, Woolf CJ.

Neuron. 2000 May;26(2):291-3. Review. No abstract available.

19.

PhosphoCREB and CREM/ICER: positive and negative regulation of proenkephalin gene expression in the paraventricular nucleus of the hypothalamus.

Borsook D, Smirnova O, Behar O, Lewis S, Kobierski LA.

J Mol Neurosci. 1999 Feb;12(1):35-51.

PMID:
10636469
20.

Semaphorin 3A growth cone collapse requires a sequence homologous to tarantula hanatoxin.

Behar O, Mizuno K, Badminton M, Woolf CJ.

Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13501-5.

21.

Role of semaphorin III in the developing rodent trigeminal system.

Ulupinar E, Datwani A, Behar O, Fujisawa H, Erzurumlu R.

Mol Cell Neurosci. 1999 Apr;13(4):281-92.

22.

A novel transmembrane semaphorin can bind c-src.

Eckhardt F, Behar O, Calautti E, Yonezawa K, Nishimoto I, Fishman MC.

Mol Cell Neurosci. 1997;9(5-6):409-19.

PMID:
9361278
23.

Semaphorin III is needed for normal patterning and growth of nerves, bones and heart.

Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC.

Nature. 1996 Oct 10;383(6600):525-8.

PMID:
8849723
24.
25.

Lipopolysaccharide induces proenkephalin gene expression in rat lymph nodes and adrenal glands.

Behar O, Ovadia H, Polakiewicz RD, Rosen H.

Endocrinology. 1994 Jan;134(1):475-81.

PMID:
8275961
26.

Regulation of proenkephalin expression in cultured skin mesenchymal cells.

Polakiewicz RD, Behar OZ, Comb MJ, Rosen H.

Mol Endocrinol. 1992 Mar;6(3):399-408.

PMID:
1584216
27.
28.

Regulated expression of proenkephalin A in normal lymphocytes.

Rosen H, Behar O, Abramsky O, Ovadia H.

J Immunol. 1989 Dec 1;143(11):3703-7.

PMID:
2584715

Supplemental Content

Support Center